These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24670309)

  • 1. Venous reddening as a possible sign of hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis for moyamoya disease: case report.
    Machida T; Ono J; Nomura R; Fujikawa A; Nagano O; Higuchi Y
    Neurol Med Chir (Tokyo); 2014; 54(10):827-31. PubMed ID: 24670309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Seizure following superficial temporal-middle cerebral artery anastomosis in patients with moyamoya disease: possible contribution of postoperative cerebral hyperperfusion].
    Narisawa A; Fujimura M; Shimizu H; Tominaga T
    No Shinkei Geka; 2007 May; 35(5):467-74. PubMed ID: 17491342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic value of perfusion-weighted MRI for evaluating postoperative alteration of cerebral hemodynamics following STA-MCA anastomosis in patients with moyamoya disease].
    Fujimura M; Mugikura S; Shimizu H; Tominaga T
    No Shinkei Geka; 2006 Aug; 34(8):801-9. PubMed ID: 16910493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of Quantitative Cerebral Blood Flow Measurement in the Acute Stage after Revascularization Surgery for Adult Moyamoya Disease: Implication for the Pathological Threshold of Local Cerebral Hyperperfusion.
    Kameyama M; Fujimura M; Tashiro R; Sato K; Endo H; Niizuma K; Mugikura S; Tominaga T
    Cerebrovasc Dis; 2019; 48(3-6):217-225. PubMed ID: 31812964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and Risk Factors of the Watershed Shift Phenomenon after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis for Adult Moyamoya Disease.
    Tashiro R; Fujimura M; Kameyama M; Mugikura S; Endo H; Takeuchi Y; Tomata Y; Niizuma K; Tominaga T
    Cerebrovasc Dis; 2019; 47(3-4):178-187. PubMed ID: 31121577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Asymptomatic intracerebral hemorrhage under strict blood pressure control due to postoperative cerebral hyperperfusion in a patient with moyamoya disease].
    Ito A; Fujimura M; Inoue T; Tominaga T
    No Shinkei Geka; 2011 Jul; 39(7):681-6. PubMed ID: 21719912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease.
    Fujimura M; Kaneta T; Mugikura S; Shimizu H; Tominaga T
    Surg Neurol; 2007 Mar; 67(3):273-82. PubMed ID: 17320638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal change of 3-T magnetic resonance imaging/angiography during symptomatic cerebral hyperperfusion following superficial temporal artery-middle cerebral artery anastomosis in a patient with adult-onset moyamoya disease.
    Kohama M; Fujimura M; Mugikura S; Tominaga T
    Neurosurg Rev; 2008 Oct; 31(4):451-5; discussion 455. PubMed ID: 18548300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease.
    Fujimura M; Mugikura S; Kaneta T; Shimizu H; Tominaga T
    Surg Neurol; 2009 Apr; 71(4):442-7. PubMed ID: 18514264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranial-intracranial bypass for moyamoya disease: comparative study with non-moyamoya patients using N-isopropyl-p-[(123)I]iodoamphetamine single-photon emission computed tomography.
    Fujimura M; Shimizu H; Inoue T; Mugikura S; Saito A; Tominaga T
    Neurosurgery; 2011 Apr; 68(4):957-64; discussion 964-5. PubMed ID: 21221039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptomatic hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in a child with moyamoya disease.
    Fujimura M; Kaneta T; Shimizu H; Tominaga T
    Childs Nerv Syst; 2007 Oct; 23(10):1195-8. PubMed ID: 17486352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of Cerebral Hyperperfusion after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis by Three-Dimensional-Time-of-Flight Magnetic Resonance Angiography in Adult Patients with Moyamoya Disease.
    Nishizawa T; Fujimura M; Katsuki M; Mugikura S; Tashiro R; Sato K; Tominaga T
    Cerebrovasc Dis; 2020; 49(4):396-403. PubMed ID: 32829323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors of symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in adult patients with moyamoya disease.
    Hwang JW; Yang HM; Lee H; Lee HK; Jeon YT; Kim JE; Lim YJ; Park HP
    Br J Anaesth; 2013 May; 110(5):773-9. PubMed ID: 23274781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uneven cerebral hemodynamic change as a cause of neurological deterioration in the acute stage after direct revascularization for moyamoya disease: cerebral hyperperfusion and remote ischemia caused by the 'watershed shift'.
    Tu XK; Fujimura M; Rashad S; Mugikura S; Sakata H; Niizuma K; Tominaga T
    Neurosurg Rev; 2017 Jul; 40(3):507-512. PubMed ID: 28357585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-of-Flight MR Angiography for Detection of Cerebral Hyperperfusion Syndrome after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis in Moyamoya Disease.
    Sato K; Yamada M; Kuroda H; Yamamoto D; Asano Y; Inoue Y; Fujii K; Kumabe T
    AJNR Am J Neuroradiol; 2016 Jul; 37(7):1244-8. PubMed ID: 26939637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of prophylactic blood pressure lowering according to a standardized postoperative management protocol to prevent symptomatic cerebral hyperperfusion after direct revascularization surgery for moyamoya disease.
    Fujimura M; Inoue T; Shimizu H; Saito A; Mugikura S; Tominaga T
    Cerebrovasc Dis; 2012; 33(5):436-45. PubMed ID: 22456617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biphasic Development of Focal Cerebral Hyperperfusion After Revascularization Surgery for Adult Moyamoya Disease Associated With Autosomal Dominant Polycystic Kidney Disease.
    Tashiro R; Fujimura M; Endo H; Endo T; Niizuma K; Tominaga T
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3256-3260. PubMed ID: 30093201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient crossed cerebellar diaschisis due to cerebral hyperperfusion following surgical revascularization for moyamoya disease: case report.
    Hokari M; Kuroda S; Simoda Y; Uchino H; Hirata K; Shiga T; Nakayama N; Houkin K; Tamaki N
    Neurol Med Chir (Tokyo); 2012; 52(5):350-3. PubMed ID: 22688075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Hyperspectral Imaging System for Intraoperative Prediction of Cerebral Hyperperfusion Syndrome after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis in Patients with Moyamoya Disease.
    Iwaki K; Takagishi S; Arimura K; Murata M; Chiba T; Nishimura A; Ren N; Iihara K
    Cerebrovasc Dis; 2021; 50(2):208-215. PubMed ID: 33596563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of superficial temporal artery-middle cerebral artery anastomosis with routine postoperative cerebral blood flow measurement during the acute stage in childhood moyamoya disease.
    Fujimura M; Kaneta T; Tominaga T
    Childs Nerv Syst; 2008 Jul; 24(7):827-32. PubMed ID: 18066556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.